Inspire Medical Systems, Inc. Stock price

Equities

INSP

US4577301090

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-03-01 pm EST 5-day change 1st Jan Change
183.5 USD +2.50% Intraday chart for Inspire Medical Systems, Inc. -0.77% -9.79%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Sales 2024 * 781M Sales 2025 * 947M Capitalization 5.43B
Net income 2024 * -9M Net income 2025 * 24M EV / Sales 2024 * 6.33 x
Net cash position 2024 * 483M Net cash position 2025 * 594M EV / Sales 2025 * 5.11 x
P/E ratio 2024 *
-447 x
P/E ratio 2025 *
233 x
Employees 1,011
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.2%
More Fundamentals * Assessed data
Dynamic Chart
UBS Adjusts Inspire Medical Systems Price Target to $265 From $220, Maintains Buy Rating MT
Mizuho Adjusts Price Target on Inspire Medical Systems to $250 From $225, Maintains Buy Rating MT
Inspire Medical Systems Q4 Net Income, Revenue Rise; Reaffirms 2024 Revenue Outlook MT
Transcript : Inspire Medical Systems, Inc., Q4 2023 Earnings Call, Feb 06, 2024
Earnings Flash (INSP) INSPIRE MEDICAL SYSTEMS Reports Q4 Revenue $192.5M, vs. Street Est of $191.2M MT
Inspire Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Inspire Medical Systems, Inc. Reaffirms Revenue Guidance for the Full Year 2024 CI
Inspire Medical Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Inspire Medical Systems Names CEO Timothy P. Herbert as Board Chair MT
Inspire Medical Systems, Inc. Announces Board Retirements CI
Inspire Medical Systems, Inc. Announces Jerry C. Griffin, M.D. from Its Board of Directors, Effective on May 2, 2024 CI
Jefferies Initiates Inspire Medical Systems With Buy Rating, Price Target is $245 MT
Transcript : Inspire Medical Systems, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 07:30 AM
Inspire Medical Systems Reports Preliminary Q4, Full Year 2023 Revenue; Issues 2024 Revenue Guidance MT
Inspire Medical Systems, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023 and Full Year 2024 CI
More news
1 day+2.50%
1 week-0.77%
Current month+2.50%
1 month-15.83%
3 months+20.96%
6 months-23.17%
Current year-9.79%
More quotes
1 week
177.07
Extreme 177.0675
186.74
1 month
177.07
Extreme 177.0675
226.38
Current year
163.57
Extreme 163.57
226.38
1 year
123.27
Extreme 123.27
330.00
3 years
123.27
Extreme 123.27
330.00
5 years
40.53
Extreme 40.53
330.00
10 years
22.50
Extreme 22.5
330.00
More quotes
Managers TitleAgeSince
Founder 61 07-10-31
Director of Finance/CFO 56 14-05-15
Chief Tech/Sci/R&D Officer 61 22-07-27
Members of the board TitleAgeSince
Director/Board Member 66 19-07-24
Chairman 84 16-10-31
Director/Board Member 79 07-12-31
More insiders
Date Price Change Volume
24-03-01 183.5 +2.50% 370,636
24-02-29 179 +0.81% 386,709
24-02-28 177.6 -3.96% 502,638
24-02-27 184.9 +1.47% 497,720
24-02-26 182.3 -1.45% 369,878

Delayed Quote Nyse, March 01, 2024 at 04:00 pm EST

More quotes
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of invasive solutions for patients with obstructive sleep apnea (OSA). The obstructive sleep apnea device that treats the root cause of sleep apnea by working inside the body with the patient's natural breathing process. The Company has developed a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its system to the hospitals and ambulatory surgery centers (ASCs) in the United States and in select countries in Europe through a direct sales organization. The Company sells its Inspire system in Japan and Singapore through distributors.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
183.5 USD
Average target price
251 USD
Spread / Average Target
+36.77%
Consensus
  1. Stock
  2. Equities
  3. Stock Inspire Medical Systems, Inc. - Nyse
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW